| Particulars |
|
|
|
| Company Name
| Neuland Laboratories Ltd
| Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
12.83 |
B.V. (₹) |
1,453.60 |
| Sales(₹ Cr.) |
2,022.99 |
NP (₹ Cr.) |
363.11 |
| NP Var% |
75.00 |
Div% |
340.00 |
| CPS(₹) |
354.50 |
EPS (₹) |
283.00 |
| Traded Value(₹ Lakhs) |
481.47 |
52 Week High |
19,748.00 |
| 52 Week Low |
11,022.00 |
Price BSE |
16,634.00 |
| Price NSE |
16,693.00 |
Market Capital (₹ Cr.) |
21,341.30 |
| P/C Ratio |
46.90 |
P/E Ratio |
58.80 |
| Price Vs.BV |
11.44 |
|
| Latest Quarter |
| Year End |
202603 |
Sales (₹ Cr.) |
776.25 |
| NP(₹ Cr.) |
212.52 |
NP Var % |
666.00 |
| Trailing Twelve Months |
| Year End |
202603 |
Sales |
1,528.28 |
| OPM |
26.99 |
NP |
263.04 |
| NP Var% |
74.97 |
EPS |
283.01 |
| PE |
58.78 |
|
|